Gordon Freeman, Arlene Sharpe Receive Inaugural Gretener-Thürlemann Prize December 4, 2025 $625,000 prize recognizes breakthrough research into cancer immunotherapy
HMS Announces Blavatnik Institute Early Career Investigator Awards November 6, 2025 10 projects receive basic and translational research funding
HMS Scientists Win Funding From Blavatnik Biomedical Accelerator September 25, 2025 New technologies take aim at urgent challenges from autoimmune disease to cancer
Addressing Twofold Lung Damage September 9, 2025 Molecule could hold a key to repairing tissue harmed by infection, inflammation
New Research Building Renamed as Veritas Science Center September 3, 2025 Underscores Harvard Medical School’s commitment to research and discovery
Research Identifies New Ways To Supercharge Cancer Immunotherapy August 12, 2025 Findings, based on mouse studies, could pave the way for more effective cancer treatments
Medicines That Unleash the Immune System To Fight Cancer July 7, 2025 The story behind the development of immune checkpoint inhibitors, fulfilling the promise of cancer…
Gordon Freeman and Arlene Sharpe Receive Hamburg Award September 26, 2024 National Academy of Medicine award recognizes contributions to cancer immunotherapy
Turbocharging CRISPR to Understand How the Immune System Fights Cancer February 28, 2024 New approach to studying immune gene function could improve treatments for cancer, other diseases
New Institute to Address Cancer, Immune, Inflammatory Diseases May 9, 2023 Historic $100 million gift given by biotech entrepreneur Gene Lay
To Boost Cancer Immunotherapy’s Fighting Power, Look to the Gut May 3, 2023 Immunotherapy has redefined cancer treatment, but not all patients experience the same benefit when…
Engineering Immunotherapy March 6, 2020 Designing new biomaterial-inspired approaches for cancer treatments
